首页> 外文期刊>Internal medicine journal >Obstructive sleep apnoea and cardiovascular disease.
【24h】

Obstructive sleep apnoea and cardiovascular disease.

机译:阻塞性睡眠呼吸暂停和心血管疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Obstructive sleep apnoea (OSA) leads to both acute and chronic physiological effects on the cardiovascular system. There is now a large amount of evidence showing that OSA is independently associated with a wide spectrum of clinical cardiovascular disease (CVD). Evidence for a causative effect of OSA is strongest for hypertension, but is weaker for other cardiovascular disorders. Large prospective trials are ongoing and when results become available the link between OSA and CVD is likely to be strengthened. Treatment of OSA with continuous positive airway pressure has been shown to improve blood pressure, particularly in those with hypertension, and also left ventricular ejection fraction in those with congestive heart failure. Given the high prevalence of OSA in the community and its effects on the cardiovascular system, symptoms of this disorder should be sought in patients being investigated or treated for CVD. (Intern Med J 2004; 34: 420-426)
机译:摘要阻塞性睡眠呼吸暂停(OSA)会对心血管系统产生急性和慢性生理影响。现在有大量证据表明OSA与多种临床心血管疾病(CVD)独立相关。 OSA致病作用的证据在高血压中最强,但在其他心血管疾病中则较弱。正在进行大规模的前瞻性试验,当获得结果时,OSA和CVD之间的联系可能会得到加强。持续气道正压通气治疗OSA已显示可改善血压,特别是在高血压患者中,在充血性心力衰竭患者中也可改善左心室射血分数。鉴于OSA在社区中的普遍流行及其对心血管系统的影响,应在接受CVD治疗或治疗的患者中寻找这种疾病的症状。 (Intern Med J 2004; 34:420-426)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号